埃拉贝拉的心血管方面:一种潜在的诊断生物标志物和治疗点
1Translational Medicine Centre, Jiangxi University of Chinese Medicine, Nanchang 330002, Jiangxi, China.
Vascular pharmacology
|July 11, 2023
概括
作为心血管平衡的调节剂,ELABELA显示了对心脏病的治疗潜力. 增强外围ELABELA可能为治疗心血管疾病 (CVD) 提供了一个有前途的策略.
科学领域:
- 心血管生物学 心血管生物学
- 内分泌学 在内分泌学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 埃拉贝拉是APJ受体的内源性连接体,对心血管平衡至关重要.
- 它在心血管系统的生理功能和病理状况中起着重要作用.
- 埃拉贝拉被认为是一种潜在的治疗标和心血管疾病 (CVD) 的诊断生物标志物.
研究的目的:
- 审查ELABELA在心血管系统中的生理和病理作用.
- 探索ELABELA作为心血管疾病治疗点的潜力.
- 讨论ELABELA在心血管恒温和发育中的功能.
主要方法:
- 关于ELABELA及其受体APJ的研究的文献综述.
- 分析ELABELA在生理和病理层面的影响.
- 检查ELABELA在心血管恒温,发育和疾病中的作用.
主要成果:
- 埃拉贝拉显示出血管新生和血管松作用,对心脏发育至关重要.
- 周围的ELABELA表现出抗高血压,血管保护和心脏保护作用.
- 中央ELABELA的管理可以提高血压,并诱导心血管重塑.
结论:
- 埃拉贝拉是心血管恒温的关键调节剂,具有双重作用.
- 外周ELABELA增强为心血管疾病提供了潜在的治疗策略.
- 埃拉贝拉水平可以作为各种心血管疾病的诊断生物标志物.
相关概念视频
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
202
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
202
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
121
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
121
Dysrhythmias V: Evaluating Dysrhythmias
42
Dysrhythmias, also known as arrhythmias, are disturbances in the heart's rhythm that range from benign to life-threatening. A thorough evaluation is crucial for appropriate management and involves a comprehensive medical history, physical examination, and various diagnostic tests.Medical HistorySymptoms: Collect detailed information on palpitations, dizziness, syncope, chest pain, and fatigue. Note their onset, frequency, and triggers.Previous Cardiac Issues: Document any history of heart...
42
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
13
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
13
Coronary Artery Disease I: Introduction
25
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
25
Coronary Artery Disease II: Pathophysiology
13
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
13


